Healthspan podcast

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

07/10/2024
0:00
11:00
Recuar 15 segundos
Avançar 15 segundos

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

Mais episódios de "Healthspan"